Back to SUSQUEHANNA INTERNATIONAL GROUP, LLP SUSQUEHANNA INTERNATIONAL GROUP, LLP

NVCTNVCT
10 quarters

Position history for SUSQUEHANNA INTERNATIONAL GROUP, LLPSUSQUEHANNA INTERNATIONAL GROUP, LLP's holdings in NUVECTIS PHARMA INC

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds 217,286 shares of NVCT (NUVECTIS PHARMA INC), worth $4M as of 2026-Q2. The position was increased (+106.4% shares). NVCT represents 0.0% of SUSQUEHANNA INTERNATIONAL GROUP, LLP's portfolio.

Current Value

$4M

Current Shares

217,286

Total Value Change

+$3.8M

Total Shares Change

+191,616

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
217,286
+106.4%
$4M0.0%$18.39
43
2026-Q1
Decreased
105,286
-21.5%
$813,8610.0%$8.71
0
2025-Q4
Increased
134,154
+47.6%
$1M0.0%$7.38
34
2025-Q3
Increased
90,879
+100.7%
$547,0920.0%$5.92
39
2025-Q2
New
45,274
-
$338,1970.0%$7.55
36
2025-Q1
Exited
0
-100.0%
$00.0%$10.46
0
2024-Q4
Increased
45,607
+72.3%
$246,7340.0%$5.14
24
2024-Q3
New
26,463
-
$166,4520.0%$6.18
34
2024-Q1
Exited
0
-100.0%
$00.0%$8.20
0
2023-Q4
New
25,670
-
$214,0880.0%$8.34
35

Other major holders of NVCT: BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used